Abstract
OBJECTIVE: To validate a revised version of the KIMRISS method for quantification of BML and synovitis-effusion in the knee by comparison with an established method, MOAKS.
METHODS: Novel calibration tools were developed for both methods. We compared reliability for status and change scores of BML and synovitis-effusion on baseline and one-year MRI scans.
RESULTS: Significant increase in both BML and synovitis-effusion was evident using KIMRISS but only for synovitis-effusion using MOAKS. Pre-specified targets for acceptable reliability (≥0.80 and ≥0.70 for status and change scores, respectively) were achieved more frequently for KIMRISS for both BML and synovitis.
CONCLUSION: Per OFISA criteria, KIMRISS should progress to assessment of discrimination.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Seminars in Arthritis and Rheumatism |
Vol/bind | 51 |
Udgave nummer | 4 |
Sider (fra-til) | 925-928 |
Antal sider | 4 |
ISSN | 0049-0172 |
DOI | |
Status | Udgivet - aug. 2021 |